Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
C Del Giovane, GB Boncoraglio, L Bertù, R Banzi… - BMC neurology, 2021 - Springer
Background Antiplatelet drugs may prevent recurrent ischemic events after ischemic stroke
but their relative effectiveness and harms still need to be clarified. Within this network meta …
but their relative effectiveness and harms still need to be clarified. Within this network meta …
Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack
IA Naqvi, AK Kamal, H Rehman - Cochrane Database of …, 2020 - cochranelibrary.com
Background Stroke is a leading cause of morbidity and mortality worldwide. Antiplatelet
agents are considered to be the cornerstone for secondary prevention of stroke, but the role …
agents are considered to be the cornerstone for secondary prevention of stroke, but the role …
[HTML][HTML] P2Y12 inhibitors plus aspirin versus aspirin alone in patients with ischemic cerebrovascular events: An updated meta-analysis of randomized controlled trials
HS Faria, RBAR de Morais, E Bulhões… - Journal of Stroke and …, 2025 - Elsevier
Background The efficacy and safety of P2Y12 inhibitors (P2Y12i) with aspirin in patients with
non-cardioembolic ischemic cerebrovascular events remains a topic of ongoing debate …
non-cardioembolic ischemic cerebrovascular events remains a topic of ongoing debate …
Cerebral sinus thrombosis secondary to SARS‐CoV‐2 infection
Coronavirus disease‐19 (COVID‐19) is a novel infectious disease and every day we are
learning more about its various clinical features and complications. Different studies during …
learning more about its various clinical features and complications. Different studies during …
P2Y12 inhibitors plus aspirin for acute treatment and secondary prevention in minor stroke and high-risk transient ischemic attack: A systematic review and meta …
F Pomero, E Galli, M Bellesini, L Maroni… - European Journal of …, 2022 - Elsevier
Background Aspirin is a cornerstone of preventive treatment for stroke recurrence, but during
the last few years the role of dual antiplatelet therapy (DAPT) is much more emerging …
the last few years the role of dual antiplatelet therapy (DAPT) is much more emerging …